MSD expects to see an additional $200m layered onto its costs this year as a result of President Trump's tariffs, ahead of any pharma-specific levy.

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports.

A New York-based start-up company wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents.

WCBS via CNN Newsource Responsible Grid is a New York-based start-up company that wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents.

I rate GRID a strong buy due to its direct focus on smart grid solutions, which are central to the modernization of global energy infrastructure.

NEW YORK, New York (WCBS) — A New York-based start-up company wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents. The pilot program ...